2238 Frisch, Daniel - Thomas Jefferson University - Thomas Jefferson University

Daniel R. Frisch, MD

Contact Dr. Frisch

925 Chestnut Street
Mezzanine Floor
Philadelphia, PA 19107

(215) 955-1167
(215) 215-503-3976 fax

Most Recent Peer-reviewed Publications

  1. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices
  2. Managed Ventricular Pacing Facilitating Atrioventricular Nodal Reentrant Tachycardia
  3. Device implantation complications during fellowship training: It is always the fellow's fault, or is it?
  4. Impact of left atrial volume on outcomes of pulmonary vein isolation in patients with non-paroxysmal (persistent) and paroxysmal atrial fibrillation
  5. Recurrent orthostatic syncope due to left atrial and left ventricular collapse after a continuous-flow left ventricular assist device implantation
  6. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: Increasing complexity of patients and procedures
  7. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008
  8. Alternating short and long RP tachycardias: What are the mechanisms?
  9. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006
  10. Cardiac resynchronization therapy: How far is too far?
  11. 'Multiblock': What is the mechanism?
  12. Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction
  13. Value of implantable cardioverter-defibrillators in managing atrial fibrillation
  14. The Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death
  15. Alternating left bundle branch block and right bundle branch block during tachycardia: What is the mechanism?
  16. Atrioventricular nodal reentrant tachycardia in two siblings with Wolfram syndrome
  17. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries
  18. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction
  19. The relationship of intracoronary stent placement following thrombolytic therapy to tissue level perfusion